Hansa Biopharma to host conference call to provide interim results for January-September 2021 and Business Update

By griffith - February 14, 2022

LUND, Sweden, Oct. 7, 2021 /PRNewswire/ — Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-September 2021 at 8:00 CET on October 21, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.

Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made available online after the call. Link to presentation

To participate in the telephone conference, please use the dial-in details provided below:

Sweden: +46 856 64 27 07

United Kingdom: +44 333 300 92 74

United States: +1 646 722 49 04

The webcast will be available on https://streams.eventcdn.net/hansa/2021q3

Updated Calendar and Events 2021/2022

Oct 21, 2021                 Interim report for Jan-Sep 2021

Oct 22+26, 2021           Kempen NDRS EU/US (virtual)

Nov 10, 2021                Ökonomisk Ugebrev Life Science Conf., Copenhagen

Nov 11, 2021                Redeye Life Science Day 2021, Stockholm

Nov 16-18, 2021           Jefferies Global Healthcare Conference, London/virtual

Nov 25, 2021                Erik Penser Banks Bolagsdag, Stockholm/virtual

Dec 1-2, 2021               Geneva European MidCap event

Jan 9-13, 2021             JPM Week, San Francisco

Jan 10-13, 2021            HC Wainwright BioConnect (virtual)

Feb 3, 2022                  Year-End report for Jan – Dec 2021

Mar 15, 2022                Carnegie Healthcare Seminar 2022, Stockholm


For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: [email protected]

Katja Margell
Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 768-198 326
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


20211005 HNSA – PR Conf call invite Q3 2021 ENG FINAL

Cision View original content:https://www.prnewswire.com/news-releases/hansa-biopharma-to-host-conference-call-to-provide-interim-results-for-january-september-2021-and-business-update-301394906.html

SOURCE Hansa Biopharma AB